Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amer A Beg

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Trends in Immunology|October 29, 2002
Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responsesAmer A Beg
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2003
Regulation of developing B cell survival by RelA-containing NF-kappa B complexesMaria Prendes, Ye Zheng, Amer A Beg
Oncoimmunology|January 10, 2014
A new role for NFκB in immunosurveillance and its implications for cancer immunotherapyAmer A Beg, Tahira Khan, Scott J Antonia
Expert Opinion on Therapeutic Targets|August 30, 2013
Non-canonical IKKs, IKKϵ and TBK1, as novel therapeutic targets in the treatment of non-small cell lung cancerJae-Young Kim, Amer A Beg, Eric B Haura
The Journal of Experimental Medicine|July 1, 2004
Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB responseSimona Saccani, Ivan Marazzi, Amer A Beg, et al.
Frontiers in Immunology|August 23, 2012
Targeting PKCθ in alloreactivity and graft-versus-host-disease: unanswered questions and therapeutic potentialCrystina C Bronk, Xue-Zhong Yu, Amer A Beg
Cancer Immunology Research|June 18, 2015
Charting Immune Signaling Proteomes En Route to New Therapeutic StrategiesEric B Haura, Amer A Beg, Uwe Rix, et al.
Immunity|March 1, 2002
Dendritic cell development and survival require distinct NF-kappaB subunitsFateh Ouaaz, Joseph Arron, Ye Zheng, et al.
Biochemical and Biophysical Research Communications|November 20, 2002
An extensively associated dimer in the structure of the C713S mutant of the TIR domain of human TLR2Xiao Tao, Yingwu Xu, Ye Zheng, et al.
The Journal of Experimental Medicine|April 2, 2003
Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo functionYe Zheng, Monika Vig, Jesse Lyons, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Trends in Immunology|October 29, 2002
Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responsesAmer A Beg
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2003
Regulation of developing B cell survival by RelA-containing NF-kappa B complexesMaria Prendes, Ye Zheng, Amer A Beg
Oncoimmunology|January 10, 2014
A new role for NFκB in immunosurveillance and its implications for cancer immunotherapyAmer A Beg, Tahira Khan, Scott J Antonia
Expert Opinion on Therapeutic Targets|August 30, 2013
Non-canonical IKKs, IKKϵ and TBK1, as novel therapeutic targets in the treatment of non-small cell lung cancerJae-Young Kim, Amer A Beg, Eric B Haura
The Journal of Experimental Medicine|July 1, 2004
Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB responseSimona Saccani, Ivan Marazzi, Amer A Beg, et al.
Frontiers in Immunology|August 23, 2012
Targeting PKCθ in alloreactivity and graft-versus-host-disease: unanswered questions and therapeutic potentialCrystina C Bronk, Xue-Zhong Yu, Amer A Beg
Cancer Immunology Research|June 18, 2015
Charting Immune Signaling Proteomes En Route to New Therapeutic StrategiesEric B Haura, Amer A Beg, Uwe Rix, et al.
Immunity|March 1, 2002
Dendritic cell development and survival require distinct NF-kappaB subunitsFateh Ouaaz, Joseph Arron, Ye Zheng, et al.
Biochemical and Biophysical Research Communications|November 20, 2002
An extensively associated dimer in the structure of the C713S mutant of the TIR domain of human TLR2Xiao Tao, Yingwu Xu, Ye Zheng, et al.
The Journal of Experimental Medicine|April 2, 2003
Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo functionYe Zheng, Monika Vig, Jesse Lyons, et al.
Pageof 6